Using multiplex chromogenic immunohistochemistry and stereological-based cell counting, they found that the majority of the TIM-3+ or galectin-9+ cells corresponded to TAMs rather than tumor cells, and that the sparse TIM-3+ TILs preferentially interacted with galectin-9+ TAMs. The gene discussed is HAVCR2; the disease is neoplasm.